Variable priority dual task training
OtherVariable priority dual task training with balance and walking exercises performed simultaneously with cognitive tasks, twice a week for six weeks
NCT Number: NCT06794177
This study was planned to investigate and compare the effects of variable and fixed priority dual task training on balance, walking skills, mobility and cognition in patients with Parkinson's disease.
Looking for future studies?
Notify Me40 year and older
All sexes
Interventional
Not applicable
Gazi Üniversitesi Tıp Fakültesi Nöroloji Anabilim Dalı, Ankara, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Variable priority dual task training with balance and walking exercises performed simultaneously with cognitive tasks, twice a week for six weeks
Fixed priority dual task training with balance and walking exercises performed simultaneously with cognitive tasks, twice a week for six weeks
Single task training with balance and walking exercises, twice a week for six weeks
Time frame: Baseline, 6 weeks
A staging system that quickly provides information in determining the degree and symptom severity of the disease
Time frame: Baseline, 6 weeks
Evaluates cognitive skills, mood, activities of daily living, motor skills, motor fluctuations, dyskinesias, and autonomic dysfunction in four parts
Time frame: Baseline, 6 weeks
It includes 14 functional activities to assess static and proactive balance. The total score ranges from 0 to 56, with higher scores indicating better balance.
Time frame: Baseline, 6 weeks
The test is designed to assess dynamic balance by measuring the maximum distance that a person can reach forward beyond arm's length without taking a step.
Time frame: Baseline, 6 weeks
It is a test method used to evaluate static balance. One foot is lifted without touching the supporting leg and the person is expected to maintain their balance for 30 seconds.
Time frame: Baseline, 6 weeks
It is a test method used to evaluate dynamic balance. Two canes are placed on a flat surface to create 4 squares. All squares are numbered. The subject starts in one square and steps in one direction into each of the four squares and then reverses direction back to the start. The time (in seconds) taken to complete the sequence is measured.
Time frame: Baseline, 6 weeks
Used to assess walking speed. Participants are asked to walk a distance of 10 meters and the time taken is recorded.
Time frame: Baseline, 6 weeks
The participant stands still at the midpoint of two cones placed 1.52 m apart and begins walking around the cones in a figure eight at his/her usual pace. The total time and number of steps taken to complete the test are recorded.
Time frame: Baseline, 6 weeks
The 3-meter distance is measured and marked. Participants are asked to walk backwards as quickly as possible with the "walk" command and to stop when they reach 3 meters. The elapsed time is recorded in seconds.
Time frame: Baseline, 6 weeks
It is used to assess functional mobility level. The participant is asked to stand up from the chair, walk 3 m, turn around, walk back to the chair and sit down. The test starts with the "walk" command and the completion time is recorded in seconds.
Time frame: Baseline, 6 weeks
UPDRS Part 2 generally is considered a psychometrically reliable tool for measuring activities of daily living outcomes in people with Parkinson's disease.
Time frame: Baseline, 6 weeks
It is used to obtain information about the difficulties experienced in daily tasks related to dual task. It consists of 10 questions, each question is scored between 0 and 4.
Time frame: Baseline, 6 weeks
It is used to evaluate individuals' visual scanning speed, executive functions, visual-motor perception, motor function, planning, organization, abstract thinking and response limitation. The test consists of 2 parts: A and B. In part A, the individual is asked to combine numbers from 1 to 25 and the completion time is recorded. In part B, the individual completes the sequence by corresponding to a number and a letter, and the completion time is recorded.
Time frame: Baseline, 6 weeks
It is a test that evaluates executive functions and the suppression of inappropriate automatic responses and provides information about frontal functions.
Time frame: Baseline, 6 weeks
It is a test that measures working memory and information processing speed. In the upper right corner of the A4 paper used in the test, there is a grid of shapes, each representing a number. In the other parts of the paper, there are randomly arranged shapes in blocks. During the test, patients are asked to match these shapes with the numbers in the grid.
Time frame: Baseline, 6 weeks
It is a test used to evaluate complex attention functions and vocabulary. It consists of animal and KAS sections. First, the patient is asked to name every animal that comes to mind in one minute, as quickly as possible. In the KAS section, the patient is asked to name every word that comes to mind, except for proper nouns and city names, with the letters K-A-S in order. The time for each letter is again one minute.
Time frame: Baseline, 6 weeks
It is a 17-question scale developed to measure fear of movement/re-injury. The scale includes parameters of injury/re-injury and fear-avoidance in work-related activities. Each item is scored between 1-4.
Hacettepe University
Other
Investigation of the Effects of Dual Task Training With Different Task Priorities on Physical Performance and Cognitive Status in Patients With Parkinson's Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07139093
Deep Brain Stimulation, Parkinson's Disease (PD)
Hamburg, Germany
View Trial DetailsNCT07651930
Anxiety Disorders, Behavior
Warsaw, Poland
View Trial DetailsNCT07625605
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS)
Elizabethton, Tennessee, United States
View Trial DetailsNCT06941779
Parkinson's Disease (PD)
Newcastle, United Kingdom
View Trial Details